Stay updated with breaking news from Devon Partnership. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Through a recent study, researchers found that people with severe alcohol disorder were able to stay off alcohol for longer when they were treated with low doses of ketamine combined with psychological therapy in a clinical trial.
Through a recent study, researchers found that people with severe alcohol disorder were able to stay off alcohol for longer when they were treated with low dose
Through a recent study, researchers found that people with severe alcohol disorder were able to stay off alcohol for longer when they were treated with low dose
People with severe alcohol disorder were able to stay off alcohol for longer when they were treated with low doses of ketamine combined with psychological therapy in a clinical trial.
Toronto, Ontario--(Newsfile Corp. - December 15, 2021) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company developing and delivering psychedelic therapeutics